Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ACP3 | P15309 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.38 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.38 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11650406 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL1556229 | 0.87 | ALDH1A1 (0.60) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL477685 | 0.79 | LMNA (0.53) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL30986717 | 0.79 | LMNA (0.53) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL477543 | 0.79 | LMNA (0.53) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL477696 | 0.79 | LMNA (0.53) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL5012390 | 0.78 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL40516 | 0.78 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL10734251 | 0.78 | ALDH1A1 (0.50) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL5010807 | 0.77 | ALDH1A1 (0.54) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5354772-A | Anticholesterol agents | SANDOZ PHARM. CORP. (US) | 1994-10-11 | — | — | US | disclosed |
| EP-0200736-B1 | PYRAZOLE ANALOGS OF MEVALONOLACTONE AND DERIVATIVES THEREOF, PROCESSES FOR THEIR PRODUCTION AND THEIR USE | SANDOZ AG (CH) | 1991-04-24 | — | — | EP | disclosed |
| US-5001255-A | Idene analogs of mevalonolactone and derivatives thereof | SANDOZ PHARM. CORP. (US) | 1991-03-19 | — | — | US | disclosed |
| EP-0216785-B1 | INDENE ANALOGS OF MEVALONOLACTONE AND DERIVATIVES THEREOF | SANDOZ AG (CH) | 1991-01-30 | — | — | EP | disclosed |
| US-4973704-A | ANTICHOLESTEROL AGENTS | SANDOZ PHARM. CORP. (US) | 1990-11-27 | — | — | US | disclosed |
| EP-0235164-B1 | IMIDAZOLE ANALOGS OF MEVALONOLACTONE AND DERIVATIVES THEREOF | SANDOZ AG (CH) | 1990-07-25 | — | — | EP | disclosed |
| US-4939159-A | Azaindole derivatives useful as cholesterol biosynthesis inhibitors | SANDOZ PHARM. CORP. (US) | 1990-07-03 | — | — | US | disclosed |
| US-4876280-A | ANTICHOLESTEROL AGENTS; ATHEROSCLEROSIS; ANTILIPEMICS | SANDOZ PHARM. CORP. (US) | 1989-10-24 | — | — | US | disclosed |
| EP-0327500-A2 | 5-Substituted 1H-pyrazolo[3,4-b]pyridine derivatives, their preparation and pharmaceutical compositions containing them | SANDOZ AG (CH) | 1989-08-09 | — | — | EP | disclosed |
| US-4851427-A | INHJIBITORS OF CHOLESTEROL BIOSYNTHESIS | SANDOZ PHARM. CORP. (US) | 1989-07-25 | — | — | US | disclosed |
| EP-0221025-A1 | Heterocyclic analogs of mevalonolactone and derivatives thereof, processes for their production and their use as pharmaceuticals | SANDOZ AG (CH) | 1987-05-06 | — | — | EP | disclosed |
| EP-0216785-A1 | INDENE ANALOGS OF MEVALONOLACTONE AND DERIVATIVES THEREOF. | SANDOZ AG (CH) | 1987-04-08 | — | — | EP | disclosed |
| WO-1986007054-A1 | IMIDAZOLE ANALOGS OF MEVALONOLACTONE AND DERIVATIVES THEREOF | SANDOZ AG (CH) | 1986-12-04 | — | — | WO | disclosed |
| EP-0200736-A1 | PYRAZOLE ANALOGS OF MEVALONOLACTONE AND DERIVATIVES THEREOF, PROCESSES FOR THEIR PRODUCTION AND THEIR USE. | SANDOZ AG (CH) | 1986-11-12 | — | — | EP | disclosed |
| EP-0117228-B1 | ANALOGS OF MEVALONOLACTONE AND DERIVATIVES THEREOF, PROCESSES FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS PHARMACEUTICALS | SANDOZ AG (CH) | 1986-11-05 | — | — | EP | disclosed |
| US-4613610-A | TREATING ATHEROSCLEROSIS AND HYPERLIPEMIA | SANDOZ PHARMACEUTICALS CORP. (US) | 1986-09-23 | — | — | US | disclosed |
| WO-1986003488-A1 | INDENE ANALOGS OF MEVALONOLACTONE AND DERIVATIVES THEREOF | SANDOZ AG (CH) | 1986-06-19 | — | — | WO | disclosed |
| WO-1986000307-A2 | PYRAZOLE ANALOGS OF MEVALONOLACTONE AND DERIVATIVES THEREOF, PROCESSES FOR THEIR PRODUCTION AND THEIR USE | SANDOZ AG (CH) | 1986-01-16 | — | — | WO | disclosed |
| WO-1984002903-A1 | MEVALONOLACTONE ANALOGS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS | SANDOZ AG (CH) | 1984-08-02 | — | — | WO | disclosed |
| WO-1984002131-A1 | ANALOGS OF MEVALOLACTONE AND DERIVATIVES THEREOF, PROCESSES FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS PHARMACEUTICALS | SANDOZ AG (CH) | 1984-06-07 | — | — | WO | disclosed |